| Literature DB >> 27585512 |
Eric R Bates1, Jacqueline E Tamis-Holland2, John A Bittl3, Patrick T O'Gara4, Glenn N Levine5.
Abstract
Recent randomized controlled trials have suggested that patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease may benefit more from multivessel percutaneous coronary intervention (PCI) compared with culprit vessel-only primary PCI. The American College of Cardiology, American Heart Association, and Society for Cardiovascular Angiography and Interventions recently published an updated recommendation on this topic. The purpose of this State-of-the-Art Review is to accurately document existing published reports, describe their limitations, and establish a base for future studies.Entities:
Keywords: myocardial ischemia; myocardial revascularization; outcome assessment
Mesh：
Year: 2016 PMID： 27585512 DOI： 10.1016/j.jacc.2016.05.086
Source DB: PubMed Journal: J Am Coll Cardiol ISSN： 0735-1097 Impact factor: 24.094